Literature DB >> 26707538

Exercise oxidative skeletal muscle metabolism in adolescents with cystic fibrosis.

Maarten Werkman1, Jeroen Jeneson1, Paul Helders1, Bert Arets2, Kors van der Ent2, Birgitta Velthuis3, Rutger Nievelstein3, Tim Takken1,4, Erik Hulzebos1.   

Abstract

NEW
FINDINGS: What is the central question of this study? Do intrinsic abnormalities in oxygenation and/or muscle oxidative metabolism contribute to exercise intolerance in adolescents with mild cystic fibrosis? What is the main finding and its importance? This study found no evidence that in adolescents with mild cystic fibrosis in a stable clinical state intrinsic abnormalities in skeletal muscle oxidative metabolism seem to play a clinical significant role. Based on these results, we concluded that there is no metabolic constraint to benefit from exercise training. Patients with cystic fibrosis (CF) are reported to have limited exercise capacity. There is no consensus about a possible abnormality in skeletal muscle oxidative metabolism in CF. Our aim was to test the hypothesis that abnormalities in oxygenation and/or muscle oxidative metabolism contribute to exercise intolerance in adolescents with mild CF. Ten adolescents with CF (12-18 years of age; forced expiratory volume in 1 s >80% of predicted; and resting oxygen saturation >94%) and 10 healthy age-matched control (HC) subjects were tested with supine cycle ergometry using near-infrared spectroscopy and (31)P magnetic resonance spectroscopy to study skeletal muscle oxygenation and oxidative metabolism during rest, exercise and recovery. No statistically significant (P > 0.1) differences in peak workload and peak oxygen uptake per kilogram lean body mass were found between CF and HC subjects. No differences were found between CF and HC subjects in bulk changes of quadriceps phosphocreatine (P = 0.550) and inorganic phosphate (P = 0.896) content and pH (P = 0.512) during symptom-limited exercise. Furthermore, we found statistically identical kinetics for phosphocreatine resynthesis during recovery for CF and HC subjects (P = 0.53). No statistically significant difference in peak exercise arbitrary units for total haemoglobin content was found between CF and HC subjects (P = 0.66). The results of this study provide evidence that in patients with mild CF and a stable clinical status (without signs of systemic inflammation and/or chronic Pseudomonas aeruginosa colonization), no intrinsic metabolic constraints and/or abnormalities in oxygenation and/or muscle oxidative metabolism contribute to exercise intolerance.
© 2015 The Authors. Experimental Physiology © 2015 The Physiological Society.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26707538      PMCID: PMC4925307          DOI: 10.1113/EP085425

Source DB:  PubMed          Journal:  Exp Physiol        ISSN: 0958-0670            Impact factor:   2.969


  33 in total

1.  An MR-compatible bicycle ergometer for in-magnet whole-body human exercise testing.

Authors:  Jeroen A L Jeneson; Joep P J Schmitz; Peter A J Hilbers; Klaas Nicolay
Journal:  Magn Reson Med       Date:  2010-01       Impact factor: 4.668

2.  Respiratory muscle work compromises leg blood flow during maximal exercise.

Authors:  C A Harms; M A Babcock; S R McClaran; D F Pegelow; G A Nickele; W B Nelson; J A Dempsey
Journal:  J Appl Physiol (1985)       Date:  1997-05

3.  Impaired aerobic function in patients with cystic fibrosis during ramp exercise.

Authors:  Zoe Louise Saynor; Alan Robert Barker; Patrick John Oades; Craig Anthony Williams
Journal:  Med Sci Sports Exerc       Date:  2014-12       Impact factor: 5.411

4.  Oxygen uptake kinetics are slowed in cystic fibrosis.

Authors:  Helge Hebestreit; Alexandra Hebestreit; Andreas Trusen; Richard L Hughson
Journal:  Med Sci Sports Exerc       Date:  2005-01       Impact factor: 5.411

5.  Muscle size and cardiorespiratory response to exercise in cystic fibrosis.

Authors:  C Moser; P Tirakitsoontorn; E Nussbaum; R Newcomb; D M Cooper
Journal:  Am J Respir Crit Care Med       Date:  2000-11       Impact factor: 21.405

6.  The signal transduction function for oxidative phosphorylation is at least second order in ADP.

Authors:  J A Jeneson; R W Wiseman; H V Westerhoff; M J Kushmerick
Journal:  J Biol Chem       Date:  1996-11-08       Impact factor: 5.157

Review 7.  Dynamic MRS and MRI of skeletal muscle function and biomechanics.

Authors:  Jeanine J Prompers; Jeroen A L Jeneson; Maarten R Drost; Cees C W Oomens; Gustav J Strijkers; Klaas Nicolay
Journal:  NMR Biomed       Date:  2006-11       Impact factor: 4.044

8.  Robust homeostatic control of quadriceps pH during natural locomotor activity in man.

Authors:  J A L Jeneson; F J Bruggeman
Journal:  FASEB J       Date:  2004-04-01       Impact factor: 5.191

9.  Non-invasive assessment of exercise performance in children with cystic fibrosis (CF) and non-cystic fibrosis bronchiectasis: is there a CF specific muscle defect?

Authors:  Mark Rosenthal; Indra Narang; Liz Edwards; Andrew Bush
Journal:  Pediatr Pulmonol       Date:  2009-03

10.  Reliability and validity of the habitual activity estimation scale (HAES) in patients with cystic fibrosis.

Authors:  Greg D Wells; Donna L Wilkes; Jane Schneiderman-Walker; Maryam Elmi; Elizabeth Tullis; Larry C Lands; Felix Ratjen; Allan L Coates
Journal:  Pediatr Pulmonol       Date:  2008-04
View more
  7 in total

1.  Rebuttal from Paula Rodriguez-Miguelez, Melissa L. Erickson, Kevin K. McCully and Ryan A. Harris.

Authors:  Paula Rodriguez-Miguelez; Melissa L Erickson; Kevin K McCully; Ryan A Harris
Journal:  J Physiol       Date:  2017-03-01       Impact factor: 5.182

2.  CrossTalk opposing view: Skeletal muscle oxidative capacity is not altered in cystic fibrosis patients.

Authors:  H J Erik Hulzebos; Jeroen A L Jeneson; Cornelis K van der Ent; Tim Takken
Journal:  J Physiol       Date:  2017-03-01       Impact factor: 5.182

3.  Rebuttal from Erik H. J. Hulzebos, Jeroen A. L. Jeneson, Cornelis K. van der Ent, Maarten S. Werkman and Tim Takken.

Authors:  H J Erik Hulzebos; Jeroen A L Jeneson; Cornelis K van der Ent; Maarten S Werkman; Tim Takken
Journal:  J Physiol       Date:  2017-03-01       Impact factor: 5.182

4.  Respiratory Muscle Strength and Exercise Performance in Cystic Fibrosis-A Cross Sectional Study.

Authors:  Aleksandar Sovtic; Predrag Minic; Gordana Markovic-Sovtic; Goran Z Trajkovic
Journal:  Front Pediatr       Date:  2018-09-04       Impact factor: 3.418

5.  Magnetic resonance reveals mitochondrial dysfunction and muscle remodelling in spinal muscular atrophy.

Authors:  Laura E Habets; Bart Bartels; Fay-Lynn Asselman; Melissa T Hooijmans; Sandra van den Berg; Aart J Nederveen; W Ludo van der Pol; Jeroen A L Jeneson
Journal:  Brain       Date:  2022-05-24       Impact factor: 15.255

6.  Size-adjusted muscle power and muscle metabolism in patients with cystic fibrosis are equal to healthy controls - a case control study.

Authors:  Katharina Ruf; Meinrad Beer; Herbert Köstler; Andreas Max Weng; Henning Neubauer; Alexander Klein; Kathleen Platek; Kristina Roth; Ralph Beneke; Helge Hebestreit
Journal:  BMC Pulm Med       Date:  2019-12-30       Impact factor: 3.317

Review 7.  Exercise Physiology Across the Lifespan in Cystic Fibrosis.

Authors:  Ren-Jay Shei; Kelly A Mackintosh; Jacelyn E Peabody Lever; Melitta A McNarry; Stefanie Krick
Journal:  Front Physiol       Date:  2019-11-05       Impact factor: 4.566

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.